AZERION Stock 19.19% Up On Tuesday

(VIANEWS) – The Market ended the session with AZERION (AZRN.AS) rising 19.19% to €3.54 on Tuesday, following the last session’s downward trend. AEX-Index fell 0.54% to €752.93, following the last session’s upward trend on what was a somewhat negative trend exchanging session today. AZERION’s last close was €2.97, 68.73% under its 52-week high of €9.50….

Read More

METABOLIC EXPLORER And DLTX On The List Of Winners And Losers Of Monday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are METABOLIC EXPLORER, LAVIDE HOLDING, and ERYTECH PHARMA. Rank Financial Asset Price Change Updated (EST) 1 METABOLIC EXPLORER (METEX.PA) 1.37 20.86% 2023-02-27 11:00:23 2 LAVIDE HOLDING…

Read More

FIN.OUEST AFRICAIN Stock 9.77% Up Today

(VIANEWS) – The Market ended the session with FIN.OUEST AFRICAIN (FOAF.PA) jumping 9.77% to €29.20 on Monday while CAC 40 rose 1.51% to €7,295.55. About FIN.OUEST AFRICAIN Fin.Ouest Africain provides various financial services. It offers car, personal, business risk, transportation, and other property and casualty insurance products; and life insurance products for individuals, private and…

Read More

FONCIERE EURIS Stock Bullish Momentum With A 10.87% Rise On Monday

(VIANEWS) – The Market ended the session with FONCIERE EURIS (EURS.PA) jumping 10.87% to €5.10 on Monday while CAC 40 rose 1.51% to €7,295.55. About FONCIERE EURIS Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties…

Read More

ERYTECH PHARMA Stock 15.36% Up On Monday

(VIANEWS) – The Market ended the session with ERYTECH PHARMA (ERYP.PA) rising 15.36% to €0.89 on Monday while CAC 40 jumped 1.51% to €7,295.55. ERYTECH PHARMA’s last close was €0.77, 65.86% below its 52-week high of €2.26. About ERYTECH PHARMA ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and…

Read More